BioCentury
ARTICLE | Clinical News

Digibind digoxin immune fab regulatory update

December 3, 2012 8:00 AM UTC

FDA granted Fast Track designation for Glenveigh's digoxin immune fab to treat severe preeclampsia. The polyclonal antibody fragment that neutralizes digoxin is clinical testing to treat eclampsia and...